-

Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:

  • William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 11:20 a.m. (CDT)
  • Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023 at 8:40 a.m. (PDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Contacts

Incyte

Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Gregory Shertzer
+1 302 274 4779
gshertzer@incyte.com

Industry:

Incyte

NASDAQ:INCY
Release Versions
English

Contacts

Incyte

Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Gregory Shertzer
+1 302 274 4779
gshertzer@incyte.com

More News From Incyte

Incyte to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte to Present at the Goldman Sachs 47th Annual Global Healthcare Conference...

Incyte and Edison Scientific Announce Strategic Collaboration to Employ the Kosmos AI Platform for Research and Development

WILMINGTON, Del. & SAN FRANCISCO--(BUSINESS WIRE)--Incyte and Edison Scientific Announce Strategic Collaboration to Employ the Kosmos AI Platform for Research and Development...

Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress...
Back to Newsroom